Anatara Lifesciences Ltd

ASX (AUD): Anatara Lifesciences Ltd (ANR)

Last Price

0.005

Today's Change

-0.001 (16.66%)

Day's Change

0.005 - 0.005

Trading Volume

542,291

Overview

Market Cap

1 Million

Shares Outstanding

213 Million

Avg Volume

2,140,759

Avg Price (50 Days)

0.01

Avg Price (200 Days)

0.04

PE Ratio

-0.50

EPS

-0.01

Earnings Announcement

28-Jul-2025

Previous Close

0.01

Open

0.01

Day's Range

0.005 - 0.005

Year Range

0.004 - 0.073

Trading Volume

542,291

Price Change Highlight

1 Day Change

-16.67%

5 Day Change

0.00%

1 Month Change

0.00%

3 Month Change

-91.23%

6 Month Change

-91.38%

Ytd Change

-90.00%

1 Year Change

-88.64%

3 Year Change

-91.41%

5 Year Change

-96.95%

10 Year Change

-99.23%

Max Change

-98.69%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Anatara Lifesciences Limited engages in the research, development, and commercializing of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease; and 3FDC for the treatment of anxiety, stress, or depression. The company also provides Detach for the treatment of diarrhea disease in piglets; BONIFF, a revised formulation to dry feed for piglets after weaning; and ANR-pf, a proprietary formulation for poultry water. Anatara Lifesciences Limited was incorporated in 2010 and is based in Carlton, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment